BFG
ANAB icon

Bleakley Financial Group’s AnaptysBio ANAB Stock Holding History

Bleakley Financial Group’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.89M Sell
42,761
-359
-0.8% -$21.8K 0.04% 376
2026
Q1 		$2.39M Sell
43,120
-427
-1% -$23K 0.04% 356
2025
Q4 		$2.11M Buy
43,547
+3,566
+9% +$139K 0.04% 343
2025
Q3 		$1.22M Buy
39,981
+2,430
+6% +$55.8K 0.03% 370
2025
Q2 		$834K Buy
+37,551
New +$786K 0.02% 426

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Bleakley Financial Group's ANAB Position: Q2 2026 in Review

Bleakley Financial Group reduced its AnaptysBio (ANAB) stake by 0.83% in Q2 2026, selling an estimated $21.8K and leaving 42,761 shares worth $2.89M. The position accounts for 0.04% of the portfolio, ranked #376.

Bleakley Financial Group first reported a position in ANAB in Q2 2025 and has held it in 5 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Bleakley Financial Group held 42,761 shares of AnaptysBio worth $2.89M as of Q2 2026.
  • Bleakley Financial Group sold 359 AnaptysBio shares in Q2 2026, an estimated $21.8K.
  • AnaptysBio made up 0.04% of Bleakley Financial Group's portfolio in Q2 2026, its #376 holding.
  • Bleakley Financial Group first reported a position in AnaptysBio in Q2 2025 and has held it in 5 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.